title: Second-generation TKI dasatinib inhibits proliferation of mesenchymal stem cells and osteoblast differentiation in vitro.
authors.forename: S
authors.initials: S
authors.lastname: Jönsson
authors.forename: H
authors.initials: H
authors.lastname: Hjorth-Hansen
authors.forename: B
authors.initials: B
authors.lastname: Olsson
authors.forename: H
authors.initials: H
authors.lastname: Wadenvik
authors.forename: A
authors.initials: A
authors.lastname: Sundan
authors.forename: T
authors.initials: T
authors.lastname: Standal
mesh_terms: D015153:Blotting, Western; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects*; D002478:Cells, Cultured; D000069439:Dasatinib; D006801:Humans; D066298:In Vitro Techniques; D059630:Mesenchymal Stem Cells / Q000187:drug effects*; D010006:Osteoblasts / Q000166:cytology / Q000187:drug effects*; D010012:Osteogenesis; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013844:Thiazoles / Q000494:pharmacology*
chemical_list: D019485:Bone Morphogenetic Proteins; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D012333:RNA, Messenger; D013844:Thiazoles; D011505:Protein-Tyrosine Kinases; D000069439:Dasatinib